Merck & Co. Q3 FY24: where the revenue came from and where it went
The whole income statement of Merck & Co. for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2024
- Reported
- Nov 6, 2024
Revenue$16.66B
+4% year over year
Gross profit$12.58B
76% margin
Operating profit$3.93B
24% margin
Net profit$3.16B
19% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 16.66 | 100% | +4% |
| US | 8.74 | 52% | +13% |
| EMEA | 3.58 | 21% | +8% |
| CN | 1.02 | 6% | −40% |
| JP | 0.94 | 6% | −13% |
| Latin America | 0.94 | 6% | +5% |
| Asia Pacific | 0.82 | 5% | +5% |
| Other countries | 0.62 | 4% | +33% |
| Cost of revenue | −4.08 | 24% | |
| Gross profit | 12.58 | 76% margin | +2pp |
| R&D | −5.86 | 35% | +14pp |
| SG&A | −2.73 | 17% | +1pp |
| Other | −0.06 | 0% | +0pp |
| Operating profit | 3.93 | 24% margin | +0pp |
| Other income, net | 0.16 | ||
| Tax | −0.93 | ||
| Net profit | 3.16 | 19% margin | −11pp |
416 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest